Key result
The hypertriglyceridemic waist phenotype in subjects with type 2 diabetes identified a subset with significantly higher visceral fat compared to high waist circumference alone (P<0.0001).
Why the study?
Does the hypertriglyceridemic waist phenotype identify increased visceral fat and subclinical atherosclerosis in subjects with type 2 diabetes?
Cohort (n=375)
Does the hypertriglyceridemic waist phenotype identify increased visceral fat and subclinical atherosclerosis in subjects with type 2 diabetes?
The hypertriglyceridemic waist phenotype identifies a subset of type 2 diabetes patients with greater visceral adiposity and subclinical atherosclerosis.
Hypertriglyceridemic waist may flag higher visceral fat risk in T2D; hypothesis-generating for improved stratification, pending prospective validation.
OBJECTIVE: Greater accumulation of visceral fat is strongly linked to risk of cardiovascular disease. However, elevated waist circumference by itself does not always identify individuals with increased visceral fat. RESEARCH DESIGN AND METHODS: We examined 375 subjects with type 2 diabetes from the CHICAGO cohort for presence of hypertriglyceridemic waist phenotype (waist circumference >90 cm in men or >85 cm in women, in conjunction with a plasma triglyceride concentration of > or =177 mg/dl) to determine its usefulness for identifying subjects with increased amounts of visceral fat. We divided subjects into three groups: group 1 (low waist circumference and low triglycerides; waist circumference < or =90 cm in men or < or =85 cm in women and triglyceride <177 mg/dl, n = 18), group 2 (high waist circumference and low triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides <177 mg/dl, n = 230), and group 3 (high waist circumference and high triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides > or =177 mg/dl, n = 127). RESULTS: Subjects in group 3 had significantly higher visceral fat (P < 0.0001), A1C (P < 0.01), and coronary artery calcium (P < 0.05) compared with group 2, despite similar age, BMI, and waist circumference. The relationship of the phenotype to atherosclerosis, however, was attenuated by adjustment for HDL cholesterol, triglyceride-rich lipoprotein cholesterol, apolipoprotein B, or LDL particle number. CONCLUSIONS: The presence of hypertriglyceridemic waist phenotype in subjects with type 2 diabetes identifies a subset with greater degree of visceral adiposity. This subset also has greater degree of subclinical atherosclerosis that may be related to the proatherogenic lipoprotein changes.
No takes yet. Share an insight, caveat, or question.
Sam et al. (2009) conducted a cohort in Type 2 diabetes (n=375). Hypertriglyceridemic waist phenotype vs. High waist circumference and low triglycerides was evaluated on Visceral fat (p=<0.0001). The hypertriglyceridemic waist phenotype in subjects with type 2 diabetes identified a subset with significantly higher visceral fat compared to high waist circumference alone (P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: